We have chosen CML based on our previous report that IL-4 production by iNKT cells was deficient in CML patients at diagnosis and considering the recent evidence in mice that IL-4 promotes the generation/differentiation of innate CD8(+) T cells. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.